Amgen Articles
Wyeth's 4th-qtr 2007 income climbs 18% just shy of estimates; predicts flat 2008 on generic competition
11 February 2008
Amgen sells Takeda Japanese rights to 13 drugs in a deal that could be worth up to $1.2B
11 February 2008
Vectibix: biomarker-specific benefits in mCRC
4 February 2008
57% of teen patients on Enbrel see PASI 75
21 January 2008
Three Rivers finalizes acquisition of Infergen from Valeant
21 January 2008
French drug sales rose 4%-4.5% in 2007
21 January 2008
lMediGene recruits Amgen exec Frank Mathias
7 January 2008
Cell Genesys sells technology for $12M
7 January 2008
Amgen and OGeS sign cancer Ab development deal
24 December 2007
Densomab improves BMD in cancer patients on AI therapy
24 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
Stock Commentary - New York week to Dec 10, 2007
17 December 2007
Amgen's romiplostim meets Phase III endpoints in ITP
17 December 2007
Amgen in discussions to update US ESA labels
17 December 2007
B-MS to cut 10% of workforce in a bid to save $1.5B in time for loss of Plavix patent
17 December 2007
EC grants conditional marketing authorization for Amgen's Vectibix
10 December 2007
Stock Commentary - New York week to Nov 26, 2007
3 December 2007
Amgen hires lobbyist Sally Katzen
26 November 2007
FDA OKs Mircera but ruling delays launch
26 November 2007
Amgen issued with subpoenas
19 November 2007
New biologicals are the stars of the 2007 ACR meeting
19 November 2007
"Devastating" AS ruling by the NICE condemned
19 November 2007
Japan OKs cinacalcet for CKD patients
5 November 2007
US insurer updates anemia drug policies
29 October 2007
Amgen files romiplostim NDA with US FDA
29 October 2007
Amgen wins in Roche Mircera patent suit
29 October 2007
Stock Commentary - New York - week to October 15, 2007
22 October 2007
Stock Commentary - New York week to Oct 8, 2007
15 October 2007
Amgen drops plans for Irish plant
8 October 2007
No chemo benefit with Amgen's Aranesp
8 October 2007
14th annual ECCO conference hears exciting data on combination therapy with biologics
8 October 2007
Amgen and EMEA discuss ESA prescribing
8 October 2007
Amgen to cut 675 jobs in California and Rhode Island
27 September 2007
Stock Commentary - New York week to Sept 17, 2007
24 September 2007
US biogenerics mart to reach $2B by 2016
17 September 2007
FDA panel votes against restricting ESA dose
17 September 2007
Aranesp has no negative survival impact in SCLC
17 September 2007
US oncology docs want CMS anemia drug review
10 September 2007
US Court rules in favor of Amgen
3 September 2007
Amgen to save $1B in restructuring after Aranesp sales drop
20 August 2007
Stock Commentary - New York week to Aug 13, 2007
20 August 2007
Medarex' 2nd-qtr net loss narrows to $41M
13 August 2007
ImClone's 2nd-qtr profit drops 14% to $319M
13 August 2007
Wyeth's 2nd-qtr net income climbs 12.5%
30 July 2007
Amgen/Daiichi Sankyo sign denosumab deal
23 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Amgen board ups stock repurchase $5B
23 July 2007
Stock Commentary - New York week to July 2, 2007
9 July 2007
France's drug spending up 1.4% says CNAM
25 June 2007
Amgen acquires Alantos for $300M
18 June 2007
Japan's Chuikyo adds 13 NCEs to NHI list
18 June 2007
Stock Commentary - New York week to June 4, 2007
11 June 2007
Amgen buys US renal specialist for $420M
11 June 2007
EMEA rejects MAA for Amgen's Vectibix
4 June 2007
Amgen urges rejection of TRC mini-tender
4 June 2007
Amgen names David Lacey as senior VP of Research
28 May 2007
CMS moves quickly on ESA coverage limits
21 May 2007
Stock Commentary - New York week to May 7, 2007
14 May 2007
Mederex reduces non-GAAP loss
14 May 2007
Amgen's 1st-qtr 2007 net profits up 11%
30 April 2007
Biovitrum's net sales drop 12% in 1st qtr
30 April 2007
Amgen sets two year delay on Irish facility
16 April 2007
Robert Bradway joins Amgen as CFO and executive VP
16 April 2007
John Kearney joins Amgen UK
2 April 2007
Stock Commentary - Europe - week to March 26
2 April 2007
Stock Commentary - New York week to March 26
2 April 2007
Ratiopharm unit and Neose initiate Ph I study
26 March 2007
Stock Commentary - New York week to Mar 12, 2007
26 March 2007
John de Wit to head up Amgen's UK oncology unit
19 March 2007
Stock Commentary - New York week to March 5, 2007
12 March 2007
Biovitrum's FY 2006 net profit plummets 47.4%
5 March 2007
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
